home / stock / ttoo / ttoo news

TTOO News and Press, T2 Biosystems Inc. From 05/15/24

Stock Information
Company Name: T2 Biosystems Inc.
Stock Symbol: TTOO
Market: NASDAQ
Website: t2biosystems.com
Menu
TTOO TTOO Quote TTOO Short TTOO News TTOO Articles TTOO Message Board
Get TTOO Alerts

News, Short Squeeze, Breakout and More Instantly...
TTOO - Biocryst Pharmaceuticals, T2 Biosystems, Annovis Bio among healthcare movers

2024-05-15 10:01:12 ET More on Health Care Select Sector SPDR XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care Health care is still very crowded but trades at a discount vs. history - BofA Health ca...
TTOO - OPEN, BCRX and AWIN among pre-market gainers

2024-05-15 09:25:53 ET Gainers: SINTX Technologies ( SINT ) +186% . Faraday Future Intelligent Electric ( FFIE ) +82% . Edible Garden AG EDBL +82% after Q1 earnings release . AERWINS Technologies ( AWIN ) +33% . Greenwave Technology Solu...

TTOO - T2 Biosystems Announces $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules

LEXINGTON, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 2,025,317 ...

TTOO - T2 Biosystems Announces CRG's Conversion from Preferred Stock to Common Stock

LEXINGTON, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that entities affiliated with CRG Servicing LLC (“CRG”) ha...
TTOO - T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme Disease

Filed Pursuant to Rule 433 Issuer Free Writing Prospectus dated May 6, 2024 Relating to Preliminary Prospectus dated May 6, 2024 Registration No. 333-278866 LEXINGTON, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid det...

TTOO - T2 Biosystems, Inc. (TTOO) Q1 2024 Earnings Call Transcript

2024-05-06 23:43:05 ET T2 Biosystems, Inc. (TTOO) Q1 2024 Earnings Conference Call May 06, 2024, 04:30 PM ET Company Participants Philip Taylor - IR, Gilmartin Group John Sperzel - Chairman & CEO John Sprague - CFO Conference Call Participants Kyl...

TTOO - T2 Biosystems enters into distribution agreement in Qatar

2024-05-06 16:42:11 ET More on T2 Biosystems T2 Biosystems, Inc. (TTOO) Q4 2023 Earnings Call Transcript T2 Biosystems GAAP EPS of -$2.66, revenue of $2.06M T2 Biosystems shareholders vote to convert $15M CRG debt into equity Read the full article on Seekin...
TTOO - T2 Biosystems GAAP EPS of -$2.66, revenue of $2.06M

2024-05-06 16:39:51 ET More on T2 Biosystems T2 Biosystems, Inc. (TTOO) Q4 2023 Earnings Call Transcript T2 Biosystems shareholders vote to convert $15M CRG debt into equity T2 Biosystems receives extension to comply with Nasdaq listing requirement Seeking Al...

TTOO - T2 Biosystems Announces First Quarter 2024 Financial Results

LEXINGTON, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced unaudited financial and operational results for the first quarter e...

TTOO - T2 Biosystems Announces Commercial Expansion Through Middle East Distributor

Filed Pursuant to Rule 433 Issuer Free Writing Prospectus dated May 6, 2024 Relating to Preliminary Prospectus dated May 6, 2024 Registration No. 333-278866 LEXINGTON, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid de...
Previous 10 Next 10